Clinical Trial Update: Study of of URC102 to Assess the Efficacy and Safety in Gout Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of URC102 in gout has completed; efficacy and safety results are reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• URC102 (URC102)

Snippet

Sponsor: JW Pharmaceutical | Conditions: Gout | Phase 2 | Status: COMPLETED